Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11667668 Compositions and methods for treating CNS disorders

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 7 Jun, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 7 Jun, 2023
Edits made to:
Infobox (+16 properties)
‌

 US Patent 11667668 Compositions and methods for treating CNS disorders

Infobox
Is a
Patent
Patent
0
Patent Applicant
SAGE Therapeutics
SAGE Therapeutics
0
Current Assignee
SAGE Therapeutics
SAGE Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116676680
Date of Patent
June 6, 2023
0
Patent Application Number
175452900
Date Filed
December 8, 2021
0
Patent Citations
‌
US Patent 9512165 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
0
‌
US Patent 10172871 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
0
‌
US Patent 10342810 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
0
‌
US Patent 10870677 Compositions and methods for treating CNS disorders
0
‌
US Patent 11241446 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
0
Patent Primary Examiner
‌
Timothy R Rozof
0
CPC Code
‌
C07J 43/003
0
‌
C07B 2200/05
0

Find more entities like US Patent 11667668 Compositions and methods for treating CNS disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.